Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCT2031200212Completed
Open-label trial of mirogabalin in Peripheral neuropathic pain (2 arms), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoints: Incidence of onset of diabetes mellitus, Incidence of aggravated diabetes mellitus and 1 more. Started Oct 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCT2031200212.